|
Program
|
 |
|
|
Day One: Wednesday, November 18, 2009
|
|
7:00
|
Registration & Continental Breakfast
|
|
8:00
|
Welcome
Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School
|
|
|
Opening Remarks
Scott T. Weiss, M.D., Interim Scientific Director, Partners HealthCare Center for Personalized Genetic Medicine, Professor of Medicine, Harvard Medical School, Brigham and Women's Hospital
Weiss Presentation
Podcast of Weiss Talk
Gary Gottlieb, M.D., M.B.A., President, Brigham and Women's Hospital, President- & Chief Executive Officer-Designate, Partners HealthCare System
|
|
8:45
|
Panel: Success Stories in Personalized Medicine
Moderator
Lawrence Lesko, Ph.D., Director of Clinical Pharmacology, CDER, FDA
Introducer
Felix W. Frueh, Ph.D., Director of Clinical Pharmacology, CDER, FDA
Pierre Cassigneul, Chief Executive Officer, XDx
Richard Ding, Vice President Theranostics, bioMerieux SA
Jon Friedenberg, Vice President, El Camino Hopsital
Arlene Hughes, Ph.D., Genetics Therapy Area Head, GlaxoSmithKline
|
|
10:00
|
Networking Break
|
|
10:45
|
Electronic Medical Records & Personalized Medicine
John Glaser, Ph.D., Vice President & Chief Information Officer, Partners HealthCare System
Glaser Presentation
Introducer
Jeffrey D. Miller, Managing Partner, Versum Ventures
|
|
11:15
|
Panel: The Current Revolution in Information Technology & Its Role in Personalized Medicine
Moderator: John Glaser, Ph.D., Vice President & Chief Information Officer, Partners HealthCare System
Samuel J. Aronson, Executive Director of Information Technology, Partners HealthCare Center for Personalized Genetic Medicine
Brett Davis, M.B.A., Senior Director, Health Sciences Global Business Unit, Oracle Corporation
Podcast of Davis Talk
Lori Evans, M.P.H., Chief Executive Officer, Active Health Community Solutions
Douglas Moeller, M.D., Medical Director, McKesson Health Solutions
Podcast of Moeller Talk
|
|
12:30
|
Break - transition
|
|
1:00
|
Luncheon and Presentation of the Personalized Medicine Coalition's Fifth Annual Award for Leadership in Personalized Medicine
Brook Byers, Partner, Kleiner Perkins Caufield & Byers
Introduction
Edward Abrahams, Ph.D., Executive Director, Personalized Medicine Coalition
Presentation
M. Kathleen Behrens, Ph.D., Founder, KEW Group
|
|
2:00
|
Table Discussions
Convener
Rebecca Rehm, Program Associate, Partners HealthCare Center for Personalized Genetic Medicine
|
|
3:00
|
Break - transition
|
|
3:30
|
Keynote
Gerardo Jimenez Sanchez, M.D., Ph.D., Director General, National Institute of Genomic Medicine in Mexico, Chairman, Working Party on Biotechnology, Organisation for Economic Co-operation and Development
Jimenez-Sanchez Presentation
Introducer
Robert C. Wells, Head, Biotechnology Unit, Science and Technology Policy Division, Directorate for Science, Technology and Industry, Organisation for Economic Co-operation and Development
|
|
4:00
|
Panel: Is Personalized Medicine Going to Cost Too Much?
Moderator
Susan Dentzer, Editor-in-Chief, Health Affairs
Introducer
Alfred A. Blum, Jr., Chief Development Officer, Partners HealthCare Center for Personalized Genetic Medicine
Robert S. Epstein, M.D., M.S., Senior Vice President, Medical & Analytical Affairs and Chief Medical Officer, Medco Health Solutions
John Fallon, M.D., M.B.A., FACP, Senior Vice President, Chief Physician Executive, Blue Cross Blue Shield of Massachusetts
Per Lofberg, Co-founder, Chairman & Chief Executive Officer, Generation Health
Lee Newcomer, M.D., Senior Vice President, Oncology, UnitedHealth Group
|
|
5:15-6:30
|
Reception at Elements Cafe
Host
Janice Larson, Development Associate, Partners HealthCare Center for Personalized Genetic Medicine
|
|
Day Two: Thursday, November 19, 2009
|
|
7:45
|
Registration & Continental Breakfast
|
|
8:30
|
Keynote
Sir Michael Rawlins, M.D., FMedSci, Chairman, National Institute for Health and Clinical Excellence
Podcast of Rawlins talk
Introducer
Katherine Johansen, Ph.D., Senior Scientist, Genetics and Molecular Medicine, American Medical Association
|
|
9:00
|
Where Are We in Personalized Medicine?
Jerel Davis, Ph.D., Engagement Manager, McKinsey & Company
Davis Presentation
Introducer
Jeff Elton, Ph.D., Founder, KEW Group
Nick Littlefield, Partner, Foley Hoag of Boston
Podcast of Littlefield Talk
Sheila Walcoff, Partner, McDermott Will & Emery
Introducer
Brook Byers, Partner, Kleiner Perkins Caufield & Byers
Alison Ayers, Vice President, Oncology WorldWide, Commercial Development, Pfizer
Ayers Presentation
Podcast of Ayers Talk 1
Podcast of Ayers Talk 2
Introducer
Hakan Sakul, Ph.D., Senior Director and Global Head of Diagnostics, Translational and Molecular Medicine Group Worldwide Developmentm, Pfizer Global Research & Development
|
|
10:15
|
Networking Break
|
|
10:45
|
Panel: How Can Business Accelerate Personalized Medicine?
Moderator
Frank Douglas, Ph.D., M.D., President & Chief Executive Officer, Austen BioInnovation Institute, Senior Partner, PureTech Ventures
Introducer
David Steinberg, Partner, PureTech Ventures
Noubar Afeyan, Ph.D., Managing Partner & Chief Executive Officer, Flagship Ventures
G. Steven Burrill, Chief Executive Officer, Burrill & Company
David P. King, President & Chief Executive Officer, Laboratory Corporation of America
Mark Levin, Partner, Third Rock Ventures
|
|
12:00
|
Bag Lunch
|
|
1:00
|
Interactive Case Studies on Business Strategies for Personalized Medicine
Case 1: Managing Drugs on the Forefront of Personalized Medicine: The Story of the Colorectal Cancer Drugs Erbitux and Vectibix
Case 2: The Explosion of GeneticTesting: Opportunities and Challenges
Moderators
Richard Hamermesh, D.B.A., MBA Class of 1961 Professor of Management Practice, Harvard Business School
Mara G. Aspinall, President & Chief Executive Officer, On-Q-ity
Aspinall/Hamermesh Presentation
Introducer
Thomas J. Miller, Chief Executive Officer, Division Workflow & Solutions, Siemens AG, Sector Healthcare
Discussants
Alison Ayers, Vice President, Oncology WorldWide Commercial Development, Pfizer
Stephen Eck, M.D., Ph.D.
Vice President, Translational Medicine & Pharmacogenomics, Eli Lilly & Company
|
|
2:30
|
Panel: Who Will Benefit From Personalized Medicine?
Moderator
Linda Avey, Founder, Brainstorm Research Foundation
Introducer
Nancy Simonian, M.D., Chief Medical Officer, Millennium: The Takeda Oncology Company
Daniel A. Haber, M.D., Ph.D., Director, Cancer Center, Massachusetts General Hospital, Harvard Medical School
Marc S. Sabatine, M.D., M.P.H., Associate Physician, Assistant Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School
Troyen A. Brennan, M.D., Executive Vice President and Chief Medical Officer, CVS Caremark
Vance Vanier, M.D., Chief Medical Officer, Navigenics
|
|
3:45-4:00
|
Closing Remarks
Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School
|
Past conference programs
|
|
|